Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set

被引:4
|
作者
Ganie, Mohd Ashraf [1 ,2 ]
Rashid, Aafia [2 ]
Baba, Mohammad Salem [1 ]
Zargar, Mohd Afzal [3 ]
Wani, Imtiyaz Ahmad [2 ]
Nisar, Sobia [4 ]
Wani, Ishfaq Ahmad [2 ]
Douhath, Syed [2 ]
Sriwastawa, Mukesh [5 ]
Geer, Mohd Ishaq [6 ]
Asrar, Mir Mohd [2 ]
Kutum, Rintu [7 ,8 ]
Hassan, Saqib [9 ]
Khan, Shahid [10 ]
Rafi, Wajid [11 ]
Bhat, Dil Afroz [12 ]
Showkat, Wasia [2 ]
Sahar, Tajali [2 ]
Choh, Naseer Ahmad [13 ]
Khurshid, Rabia [14 ]
Mudassar, Syed [12 ]
Shah, Zafar Amin [15 ]
Shabir, Iram
Sofi, Sanjeed Ahmad [13 ]
Gupta, Nandita [11 ]
Hafeez, Imran [16 ,17 ]
Sreenivas, Vishnubatla [18 ]
机构
[1] Sheri Kashmir Inst Med Sci, Dept Endocrinol, Srinagar, India
[2] Sheri Kashmir Inst Med Sci, Dept Clin Res, Srinagar, India
[3] Cent Univ Kashmir, Dept Life Sci, Ganderbal, India
[4] Govt Med Coll, Dept Med, Srinagar, India
[5] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY USA
[6] Univ Kashmir, Dept Pharmacol, Srinagar, India
[7] Ashoka Univ, Dept Comp Sci, Sonepath, India
[8] Ashoka Univ, Trivedi Sch Biosci, Dept Comp Sci, Sonepath, India
[9] Deemed Univ, Sathyabama Inst Sci & Technol, Sch Bio & Chem Engn, Dept Biotechnol, Chennai, India
[10] AIIMS New Delhi, Dept Lab Med, New Delhi, India
[11] All India Inst Med Sci, Dept Endocrinol, New Delhi, India
[12] Sheri Kashmir Inst Med Sci, Dept Clin Biochem, Srinagar, India
[13] Sheri Kashmir Inst Med Sci, Dept Radiodiag & Imaging, Srinagar, India
[14] Sheri Kashmir Inst Med Sci, Dept Obstet & Gynecol, Srinagar, India
[15] Sheri Kashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, India
[16] Iowa State Univ, Dept Biochem, Ames, IA USA
[17] Sheri Kashmir Inst Med Sci, Dept Cardiol, Srinagar, India
[18] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
India; metabolism; oligomenorrhoea; PCOS; phenotype; polymenorrhoea; Pre-PCOS; INSULIN-RESISTANCE; METABOLIC SYNDROME; MENSTRUAL CYCLES; WOMEN; MORPHOLOGY; CRITERIA; SPIRONOLACTONE; ASSOCIATION; ADOLESCENTS; POPULATION;
D O I
10.1111/cen.14964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivePolycystic ovary syndrome (PCOS) is a complex disorder with diverse metabolic implications. Diagnosis typically relies on oligo-amenorrhoea (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM). However, the role of polymenorrhoea in PCOS remains understudied. Additionally, limited information exists regarding metabolic disturbances in women with partial PCOS phenotypes that do not meet diagnostic criteria. This extensive database aims to provide substantial evidence on the metabolic implications of polymenorrhoea and partial PCOS phenotypes.DesignProspective observational study.Patients and MeasurementsIn this single-centre study, 6463 women with PCOS-like characteristics and 3142 age-matched healthy women were included. The study compared clinical (anthropometry, modified Ferriman Gallwey [mFG] score), hormonal (serum testosterone), and metabolic (plasma glucose, serum lipids, insulin) characteristics between women diagnosed with PCOS, those with partial PCOS phenotypes, and the healthy control groupResultsIn all, 5174 women met Rotterdam criteria for PCOS diagnosis, while 737 were classified as Pre-PCOS, including HA (n = 538), OA (n = 121), or PCOM (n = 78). Common clinical features included oligomenorrhoea (75.5%), hirsutism (82.9%), obesity (27.2%), hypertension (1.6%), metabolic syndrome (19.6%), and diabetes mellitus (5.6%). Women diagnosed with PCOS, HA only, and OA only exhibited higher average body mass index, plasma glucose levels (both fasting and 2 h after the oral glucose tolerance test), and lipid fractions in comparison to those with PCOM and the healthy controls. However, indices of insulin resistance were similar among women with PCOS, HA, PCOM, and OA, albeit higher than in the healthy controls. The polymenorrhoea subgroup (5.9%) had lower BMI and serum testosterone, but similar mFG score, plasma glucose, insulin, and lipid levels as the oligomenorrhoea subgroup.ConclusionThe metabolic disturbances observed in Pre-PCOS women highlight the need to reassess diagnostic criteria. Including the polymenorrhoea subcategory in PCOS criteria is recommended due to similar metabolic dysfunctions as the oligomenorrhoea group.
引用
收藏
页码:566 / 578
页数:13
相关论文
共 50 条
  • [1] Polycystic ovary syndrome (PCOS)
    Dewailly, D.
    Hieronimus, S.
    Mirakian, P.
    Hugues, J. -N.
    ANNALES D ENDOCRINOLOGIE, 2010, 71 (01) : 8 - 13
  • [2] Reconsidering the Polycystic Ovary Syndrome (PCOS)
    Gleicher, Norbert
    Darmon, Sarah
    Patrizio, Pasquale
    Barad, David H.
    BIOMEDICINES, 2022, 10 (07)
  • [3] Long term complications of polycystic ovary syndrome (PCOS)
    Peigne, Maeliss
    Dewailly, Didier
    ANNALES D ENDOCRINOLOGIE, 2014, 75 (04) : 194 - 199
  • [4] Polycystic Ovary Syndrome (PCOS) transition at menopause
    Shah, Duru
    Rasool, Sabahat
    JOURNAL OF MID-LIFE HEALTH, 2021, 12 (01) : 30 - 32
  • [5] Polycystic ovary syndrome (PCOS) in adolescence
    Strowitzki T.
    Gynäkologische Endokrinologie, 2005, 3 (3) : 161 - 167
  • [6] Osteoporosis in polycystic ovary syndrome (PCOS) and involved mechanisms
    Sudhakaran, Gokul
    Priya, P. Snega
    Jagan, Kannan
    Haridevamuthu, B.
    Meenatchi, Ramu
    Arockiaraj, Jesu
    LIFE SCIENCES, 2023, 335
  • [7] The role of MiRNA in polycystic ovary syndrome (PCOS)
    Chen, Baiqi
    Xu, Ping
    Wang, Jing
    Zhang, Chunping
    GENE, 2019, 706 : 91 - 96
  • [8] Microbiome and metabolism in polycystic ovary syndrome (PCOS)
    Heizmann, Wolfgang R.
    Keck, Christoph
    GYNAKOLOGE, 2021, 54 (10): : 732 - 740
  • [9] Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
    Palioura, Eleni
    Diamanti-Kandarakis, Evanthia
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2015, 16 (04) : 365 - 371
  • [10] Polycystic ovary syndrome (PCOS) in adolescence
    Strowitzki, T.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2005, 3 (03): : 161 - 166